Endocrinology and Metabolism (Aug 2022)

Long-Term Outcomes of Congenital Adrenal Hyperplasia

  • Anna Nordenström,
  • Svetlana Lajic,
  • Henrik Falhammar

DOI
https://doi.org/10.3803/EnM.2022.1528
Journal volume & issue
Vol. 37, no. 4
pp. 587 – 598

Abstract

Read online

A plethora of negative long-term outcomes have been associated with congenital adrenal hyperplasia (CAH). The causes are multiple and involve supra-physiological gluco- and mineralocorticoid replacement, excess adrenal androgens both intrauterine and postnatal, elevated steroid precursor and adrenocorticotropic hormone levels, living with a congenital condition as well as the proximity of the cytochrome P450 family 21 subfamily A member 2 (CYP21A2) gene to other genes. This review aims to discuss the different long-term outcomes of CAH.

Keywords